Q32 Bio (QTTB) EBITDA Margin (2018 - 2023)
Q32 Bio's quarterly EBITDA Margin came in at 1897.72% in Q4 2023, down 1030752.0% year-on-year from N/an in Q4 2022, and up 552.41% quarter-over-quarter from 419.47% in Q3 2023.
Q32 Bio has reported EBITDA Margin for 6 years, with the latest figure at 1897.72% in Q4 2023.
- For the quarter ending Q4 2023, EBITDA Margin fell 1030752.0% year-over-year to 1897.72%; the trailing twelve-month figure through Sep 2024 stood at 5690.07% (up 483407.0% YoY), and the FY2025 full-year result was 31.45%, changed N/A from the prior year.
- EBITDA Margin for Q4 2023 stood at 1897.72%, up from 419.47% in the prior quarter.
- The five-year high for EBITDA Margin was 12205.24% in Q4 2022, with the low at 9304.81% in Q1 2019.
- Average EBITDA Margin over 5 years is 2284.08%, with a median of 3285.29% recorded in 2022.
- Year-over-year, EBITDA Margin jumped 830449 bps in 2021 and slumped 1030752 bps in 2023.
- Tracing QTTB's EBITDA Margin over 5 years: stood at 4539.79% in 2019, then jumped by 33 bps to 3041.02% in 2020, then soared by 273 bps to 5263.47% in 2021, then soared by 132 bps to 12205.24% in 2022, then tumbled by 84 bps to 1897.72% in 2023.
- The last three EBITDA Margin figures came in at 1897.72% (Q4 2023), 419.47% (Q3 2023), and 226.99% (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.24% |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1,897.72% |
| Sep 30, 2023 | -419.47% |
| Jun 30, 2023 | -226.99% |
| Mar 31, 2023 | -250.19% |
| Dec 31, 2022 | 12,205.24% |
| Sep 30, 2022 | -4,097.51% |
| Jun 30, 2022 | -3,529.55% |
| Mar 31, 2022 | -4,690.52% |
| Dec 31, 2021 | 5,263.47% |
| Sep 30, 2021 | -1,828.32% |
| Jun 30, 2021 | -1,396.98% |
| Mar 31, 2021 | -3.79% |
| Dec 31, 2020 | -3,041.02% |
| Sep 30, 2020 | -4,986.42% |
| Jun 30, 2020 | -6,295.77% |
| Mar 31, 2020 | -6,206.12% |
| Dec 31, 2019 | -4,539.79% |
| Sep 30, 2019 | -7,094.78% |
| Jun 30, 2019 | -7,135.97% |
| Mar 31, 2019 | -9,304.81% |
| Dec 31, 2018 | -1,686.62% |
| Sep 30, 2018 | -975.97% |
| Jun 30, 2018 | -962.15% |
| Mar 31, 2018 | -947.39% |